Trending: BP Backs Targets of Higher Oil, Gas Production on Quarter
1002 GMT - BP is among the most mentioned companies across news items over the past four hours, according to Factiva data, after the British energy giant said it expects higher on-quarter upstream production. Specifically, it expects higher oil output and slightly higher production of gas and low-carbon energy, it said. This echoes the 1Q guidance set out in February when it released its full-year results, and sent shares to a six-months high, also aided by Brent crude futures--the global oil benchmark--shooting past $90 a barrel. BP also backed its full-year guidance of a slightly higher output than 2023, a sign that the company is "is hoping to quietly get on and do the job, achieving small incremental gains which should be enough to keep the market happy," AJ Bell analyst Russ Mould said in a market comment. The update follows that of closest rival Shell, which on Friday lifted its guidance for first-quarter production of integrated gas and liquefied natural gas. Dow Jones & Co. owns Factiva. (christian.moess@wsj.com)
(END) Dow Jones Newswires
April 09, 2024 06:18 ET (10:18 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track